Home » Topics » Cardiovascular, BioWorld Science

Cardiovascular, BioWorld Science
RSS

Sydnonimine derivatives for cardiovascular disorders presented by Chugai

Jan. 13, 1999

Intravenous adenosine for MI advances to phase III

Jan. 12, 1999

China Pharmaceutical University presents new antiarrhythmic series

Jan. 12, 1999

Series of Na+/H+ exchange inhibitors developed at Toa Eiyo

Jan. 12, 1999

Orally bioavailable agents for vascular wall hypertrophy described by Kissei

Jan. 12, 1999

New Canadian biotherapeutics company will develop SERP1 for antiinflammatory indications

Jan. 12, 1999

Chinese scientists design potent antihypertensive agents

Jan. 11, 1999

RPR Gencell evaluates SARP-1 gene for cardiovascular indications under agreement with LXR

Jan. 11, 1999

Pursuit of pediatric data for lisinopril will extend Zeneca's U.S. market exclusivity

Jan. 11, 1999

Physiologically active brain natriuretic peptides disclosed by Daiichi

Jan. 11, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
Amlogenyx’s AM-805 reduces amyloid plaques in AD
BioWorld Science
The potent carboxypeptidase enzyme protective protein cathepsin A (PPCA) is known to cleave the C-terminus of amyloid-β42, responsible for aggregation and...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Atai Therapeutics patents new 5-HT2 receptor agonists
BioWorld Science
Atai Therapeutics Inc. has identified new 5-HT2 receptor agonists potentially useful for the treatment of psychiatric disorders.